A Novel Motif for S-Adenosyl-l-methionine Binding by the Ribosomal RNA Methyltransferase TlyA from Mycobacterium tuberculosis
- PMID: 28031456
- PMCID: PMC5290967
- DOI: 10.1074/jbc.M116.752659
A Novel Motif for S-Adenosyl-l-methionine Binding by the Ribosomal RNA Methyltransferase TlyA from Mycobacterium tuberculosis
Abstract
Capreomycin is a potent ribosome-targeting antibiotic that is an essential component of current antituberculosis treatments, particularly in the case of multidrug-resistant Mycobacterium tuberculosis (Mtb). Optimal capreomycin binding and Mtb ribosome inhibition requires ribosomal RNA methylation in both ribosome subunits by TlyA (Rv1694), an enzyme with dual 2'-O-methytransferase and putative hemolytic activities. Despite the important role of TlyA in capreomycin sensitivity and identification of inactivating mutations in the corresponding Mtb gene tlyA, which cause resistance to capreomycin, our current structural and mechanistic understanding of TlyA action remains limited. Here, we present structural and functional analyses of Mtb TlyA interaction with its obligatory co-substrate for methyltransferase activity, S-adenosyl-l-methionine (SAM). Despite adopting a complete class I methyltransferase fold containing conserved SAM-binding and catalytic motifs, the isolated TlyA carboxyl-terminal domain exhibits no detectable affinity for SAM. Further analyses identify a tetrapeptide motif (RXWV) in the TlyA interdomain linker as indispensable for co-substrate binding. Our results also suggest that structural plasticity of the RXWV motif could contribute to TlyA domain interactions, as well as specific recognition of its two structurally distinct ribosomal RNA targets. Our findings thus reveal a novel motif requirement for SAM binding by TlyA and set the stage for future mechanistic studies of TlyA substrate recognition and modification that underpin Mtb sensitivity to capreomycin.
Keywords: Mycobacterium tuberculosis; RNA methylation; RNA methyltransferase; S-adenosylmethionine (SAM); X-ray crystallography; antibiotic resistance; isothermal titration calorimetry (ITC); protein motif; proteolysis; site-directed mutagenesis.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
Conflict of interest statement
The authors declare that they have no conflicts of interest with the contents of this article
Figures
![FIGURE 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5290967/bin/zbc0091761330001.gif)
![FIGURE 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5290967/bin/zbc0091761330002.gif)
![FIGURE 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5290967/bin/zbc0091761330003.gif)
![FIGURE 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5290967/bin/zbc0091761330004.gif)
![FIGURE 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5290967/bin/zbc0091761330005.gif)
![FIGURE 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5290967/bin/zbc0091761330006.gif)
![FIGURE 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5290967/bin/zbc0091761330007.gif)
![FIGURE 8.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5290967/bin/zbc0091761330008.gif)
Similar articles
-
50S subunit recognition and modification by the Mycobacterium tuberculosis ribosomal RNA methyltransferase TlyA.Proc Natl Acad Sci U S A. 2022 Apr 5;119(14):e2120352119. doi: 10.1073/pnas.2120352119. Epub 2022 Mar 31. Proc Natl Acad Sci U S A. 2022. PMID: 35357969 Free PMC article.
-
Insights into the mutations leading to capreomycin resistance in S-adenosyl-L-methionine binding motif in TlyA from Mycobacterium tuberculosis.J Biomol Struct Dyn. 2022;40(22):12239-12247. doi: 10.1080/07391102.2021.1969284. Epub 2021 Aug 31. J Biomol Struct Dyn. 2022. PMID: 34463210
-
Assessing capreomycin resistance on tlyA deficient and point mutation (G695A) Mycobacterium tuberculosis strains using multi-omics analysis.Int J Med Microbiol. 2019 Nov;309(7):151323. doi: 10.1016/j.ijmm.2019.06.003. Epub 2019 Jun 24. Int J Med Microbiol. 2019. PMID: 31279617
-
Role of TlyA in the Biology of Uncultivable Mycobacteria.Comb Chem High Throughput Screen. 2022;25(10):1587-1594. doi: 10.2174/1386207325666220111150923. Comb Chem High Throughput Screen. 2022. PMID: 35021968 Review.
-
Protein synthesis in Mycobacterium tuberculosis as a potential target for therapeutic interventions.Mol Aspects Med. 2021 Oct;81:101002. doi: 10.1016/j.mam.2021.101002. Epub 2021 Jul 31. Mol Aspects Med. 2021. PMID: 34344520 Review.
Cited by
-
Zn2+-Induced Conformational Change Affects the SAM Binding in a Mycobacterial SAM-Dependent Methyltransferase.ACS Omega. 2022 Sep 27;7(40):35901-35910. doi: 10.1021/acsomega.2c04555. eCollection 2022 Oct 11. ACS Omega. 2022. PMID: 36249403 Free PMC article.
-
Tuberactinomycin antibiotics: Biosynthesis, anti-mycobacterial action, and mechanisms of resistance.Front Microbiol. 2022 Aug 11;13:961921. doi: 10.3389/fmicb.2022.961921. eCollection 2022. Front Microbiol. 2022. PMID: 36033858 Free PMC article. Review.
-
50S subunit recognition and modification by the Mycobacterium tuberculosis ribosomal RNA methyltransferase TlyA.Proc Natl Acad Sci U S A. 2022 Apr 5;119(14):e2120352119. doi: 10.1073/pnas.2120352119. Epub 2022 Mar 31. Proc Natl Acad Sci U S A. 2022. PMID: 35357969 Free PMC article.
-
RNA Expression Analysis of Mycobacterial Methyltransferases Genes in Different Resistant Strains of Mycobacterium tuberculosis.Iran Biomed J. 2022 May 1;26(3):240-51. doi: 10.52547/ibj.26.3.240. Iran Biomed J. 2022. PMID: 35216515 Free PMC article.
-
16S rRNA Methyltransferases as Novel Drug Targets Against Tuberculosis.Protein J. 2022 Feb;41(1):97-130. doi: 10.1007/s10930-021-10029-2. Epub 2022 Feb 3. Protein J. 2022. PMID: 35112243 Review.
References
-
- World Health Organization (2015) Global Tuberculosis Report 2015, 20th Ed., World Health Organization, Geneva, Switzerland
-
- Dorman S. E., and Chaisson R. E. (2007) From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis. Nat. Med. 13, 295–298 - PubMed
-
- Mukherjee J. S., Rich M. L., Socci A. R., Joseph J. K., Virú F. A., Shin S. S., Furin J. J., Becerra M. C., Barry D. J., Kim J. Y., Bayona J., Farmer P., Smith Fawzi M. C., and Seung K. J. (2004) Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 363, 474–481 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources